Coronavirus disease (COVID-19) News

Kenya needs Sh30 billion to vaccinate 60pc of population

Kenya will need at least Sh30 billion to vaccinate 60 per cent of its population, the proportion estimated to ensure proper immunity against Covid-19.

Amref chief executive Githinji Gitahi yesterday said an average dose of a vaccine, on the lowest cadre would roughly go for Sh500. For proper immunity, the population will need to take the dose two times in 28 days.

Sixty per cent of the population is about 30 million Kenyans.

Dr Gitahi said Kenya would require Sh10 billion for the first phase of the vaccination targeting high priority groups like health care workers, teachers, security officers and the elderly who account for at least 20 per cent of the population.

Kenyans have been cautioned not to celebrate yet even as several international pharmaceutical firms announcing breakthroughs in vaccine development.

COVID-19 sceptics

Dr Gitahi spoke at an Amref press briefing on the Covid-19, vaccines, female genital mutilation and early/forced marriages in Kenya.

He praised scientists across the world for quickly developing coronavirus vaccines. Vaccine formulation usually takes up to a decade.

However, this fast making of the vaccines poses a challenge on how best they should be administered as the virus ravages the globe.

“When it comes to vaccination, we need to take into account many things. These include the actual giving of the vaccine to people. Do we have the right syringes? Are the right people being vaccinated? Is it the right time to administer the vaccine? Does the country have enough doses for everyone?” Dr Gitahi asked.

The Amref head attributed the quick success in developing the vaccines to the SARS and MERS epidemics that hit parts of Asia years ago.

He said the epidemics gave scientists a clue of what to work on.

He warned of a third wave of the virus, especially during the festive season.

Amref released a report showing many young people acknowledge Covid-19 is real but 74 per cent do not believe they can contract it.

The authors of the study attribute the situation to misinformation.

Article first published on nation.africa

Amref Health Africa

Amref Health Africa teams up with African communities to create lasting health change.

Recent Posts

Western Kenya Deworms More Than 5 Million People in an Ambitious Bid to Eliminate Intestinal Worms and Bilharzia

In four counties of western Kenya, a silent but intense battle is being fought against…

2 days ago

Promoting Indigenous Knowledge for Climate Action

In 1986, Mzee Lepoo watched his father save their village from devastating floods. By observing…

4 days ago

Site Inspection for PSA Oxygen-Generating Plants in Six Hospitals

Amref Health Africa in Kenya in partnership with Global Fund has successfully constructed and carried…

2 weeks ago

Call for Nominations: AHAIC 2025 Women in Global Health Awards to Honour Africa’s Most Inspiring Changemakers

Nairobi, 7 February 2025: In the lead-up to International Women's Day 2025, the Africa Health Agenda International…

2 weeks ago

At the World Economic Forum, UNFPA’s private sector champions commit to workplace reproductive health policies reaching more than 300,000 employees

DAVOS, Switzerland – At this year’s World Economic Forum, UNFPA and private sector partners Amref, Bayer,…

1 month ago

Financing the Future: Strengthening Health Systems Amidst the Climate and Health Crisis

Climate change is projected to cause approximately 250,000 additional deaths annually between 2030 and 2050, with undernutrition,…

1 month ago